Smith & Nephew plc 1.9% Potential Decrease Indicated by UBS

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Smith & Nephew plc using EPIC/TICKER code (LON:SN) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘NEUTRAL’ today by analysts at UBS. Smith & Nephew plc are listed in the Health Care sector within UK Main Market. UBS have set a target price of 1390 GBX on its stock. This would imply the analyst believes there is a potential downside of -1.9% from today’s opening price of 1417.5 GBX. Over the last 30 and 90 trading days the company share price has decreased 46.5 points and increased 149.5 points respectively. The 1 year high for the stock price is 1548.5 GBX while the year low share price is currently 1173 GBX.

Smith & Nephew plc has a 50 day moving average of 1,452.48 GBX and a 200 Day Moving Average share price is recorded at 1,384.28. There are currently 875,767,908 shares in issue with the average daily volume traded being 2,948,756. Market capitalisation for LON:SN is £12,263,571,525 GBP.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Smith & Nephew's Q3 2024 update shows a 4% revenue growth to $1,412M. Despite China headwinds, US Orthopaedics and Sports Medicine excelled.
    Smith & Nephew plc (LON:SN, NYSE:SNN) reports a robust financial performance for Q2 and H1 2024, showing significant revenue and profit growth.
    Smith+Nephew plc (LON:SN, NYSE:SNN) reports Q1 revenue of $1,386 million, up 2.9% underlying. Orthopaedics and Sports Medicine show strong growth. CEO confident in outlook.
    Smith+Nephew plc reports solid financial results for Q4 and full year 2023, showcasing growth in revenue and profit margins. Analyst call scheduled for 27 Feb 2024.
    Smith+Nephew plc (LON:SN, NYSE:SNN) will be attending AAOS 2024 Annual Meeting to showcase its innovative medical technology solutions in San Francisco. Learn about their latest products and updates in the orthopaedic field.

      Search

      Search